The companies had initially announced in August that the bespoke vaccine led to significant and clinically meaningful ...

Moderna (MRNA) stock crashed Thursday after a third-party leaked the purported cancer vaccine data ahead of a ...

Moderna and Merck's personalized mRNA vaccine, combined with Keytruda, reduces melanoma recurrence or death risk in Phase 3 ...

Merck (MRK) stock fell 0.67% to $148.87 despite strong Phase 3 melanoma trial results with Moderna, showing lower recurrence and metastasis risks with KEYTRUDA.

Merck partners with NVIDIA, Microsoft & Dawn Health to develop innovative model for PSPs for patients with rare tumours: Darmstadt, Germany Friday, October 23, 2026, 09:00 Hrs [IS ...

Rhenus deploys smart picking technology at its Strasbourg logistics hub for Merck, combining automated weight checks and ...

Moderna and Merck said on Thursday that their mRNA cancer vaccine when combined with Merck's widely used immunotherapy cut ...

German science and technology company Merck opened a new semiconductor materials plant in South Korea on Thursday, expanding ...

Merck KGaA (ETR:MRK) has opened a molybdenum production facility in South Korea as demand grows for the metal in advanced ...

Merck has opened a semiconductor materials plant in South Korea to produce molybdenum compounds for advanced 3D NAND memory.

At the European Society for Medical Oncology meeting this weekend, Merck will showcase three late-stage trials of its ...

German company Merck will hold a ceremony on the 22nd to open a production facility for next-generation semiconductor ...